Bayliss John B PhD - Chelsea, Massachusetts 02150

Bayliss John B PhD is categorized under Doctors in Chelsea, MA .

Business Name: Bayliss John B PhD
Contact Person: John Bayliss
Address: 111 Everett Avenue # 2b, Chelsea, Massachusetts 02150
Phone Number: (617) 889-1545
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6213993
Share This Business:
Related Businesses: Muscolo Gabriella F MD - Chelsea, MA 02150
Kehoe Laura G MD - Chelsea, MA 02150
Tipirneni Renuka MD - Chelsea, MA 02150
Community Substance Abuse - Chelsea, MA 02150
Son T Ho - Chelsea, MA 02150
Brodsky Lynne MD - Chelsea, MA 02150
Abrego Jose MD - Chelsea, MA 02150
Levine Cindy B MD - Chelsea, MA 02150
Atkinson Skip MD - Chelsea, MA 02150
Marshall Mallika J MD - Chelsea, MA 02150
Lewis Victor A MD - Chelsea, MA 02150
Sibert Lisa MD - Chelsea, MA 02150
Richards Sarah J MD - Chelsea, MA 02150
Rieger Ilse MD - Chelsea, MA 02150
Ross Susan D MD - Chelsea, MA 02150
Austria Julieta B MD - Chelsea, MA 02150
Gomez Herman MD - Chelsea, MA 02150
Gonzalez Wanda MD - Chelsea, MA 02150
Nelson Sara MD - Chelsea, MA 02150
Atkins Elisha H MD - Chelsea, MA 02150

The company Bayliss John B PhD provides B2C services in the form of Doctors from its single location in Massachusetts. 1 to 4 employees work for Bayliss John B PhD, and the business now earns $100.000 to $499.999 per annum.

Bayliss John B PhD was launched in 2001 and is classified under SIC code and category 8011 , and NAICS number and grouping 6213993 . To contact Bayliss John B PhD, please call John Bayliss with the phone number (617) 889-1545 or visit its single location at 111 Everett Avenue # 2b in Chelsea, Massachusetts 02150.

The location of the single location can also be found using the coordinates 42.39433,-71.03924. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.